Lymphoma Stocks List

Recent Signals

Date Stock Signal Type
2019-08-23 BPTH NR7 Range Contraction
2019-08-23 BPTH Bollinger Band Squeeze Range Contraction
2019-08-23 CALA Doji - Bullish? Reversal
2019-08-23 CGIX New 52 Week Closing Low Bearish
2019-08-23 CNST Expansion Breakdown Bearish Swing Setup
2019-08-23 EGRX Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-08-23 EGRX Fell Below 20 DMA Bearish
2019-08-23 IMGN 20 DMA Resistance Bearish
2019-08-23 IMGN New Downtrend Bearish
2019-08-23 IMGN Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-08-23 JAZZ Lower Bollinger Band Walk Weakness
2019-08-23 JAZZ Cup with Handle Other
2019-08-23 JAZZ Stochastic Reached Oversold Weakness
2019-08-23 MRTX Lower Bollinger Band Walk Weakness
2019-08-23 NEO Fell Below 20 DMA Bearish
2019-08-23 NEO MACD Bearish Signal Line Cross Bearish
2019-08-23 SGEN Cup with Handle Other
2019-08-23 SGEN Bollinger Band Squeeze Range Contraction
2019-08-23 SGEN Fell Below 20 DMA Bearish
2019-08-23 SGEN MACD Bearish Signal Line Cross Bearish
2019-08-23 TEVA Fell Below 20 DMA Bearish
2019-08-23 TGTX Stochastic Reached Oversold Weakness

Lymphoma is a group of blood cancers that develop from lymphocytes (a type of white blood cell). The name often refers to just the cancerous versions rather than all such tumors. Signs and symptoms may include enlarged lymph nodes, fever, drenching sweats, unintended weight loss, itching, and constantly feeling tired. The enlarged lymph nodes are usually painless. The sweats are most common at night.There are dozens of subtypes of lymphomas. The two main categories of lymphomas are Hodgkin's lymphomas (HL) and the non-Hodgkin lymphomas (NHL). The World Health Organization (WHO) includes two other categories as types of lymphoma: multiple myeloma and immunoproliferative diseases. About 90% of lymphomas are non-Hodgkin lymphomas. Lymphomas and leukemias are a part of the broader group of tumors of the hematopoietic and lymphoid tissues.Risk factors for Hodgkin lymphoma include infection with Epstein–Barr virus and a history of the disease in the family. Risk factors for common types of non-Hodgkin lymphomas include autoimmune diseases, HIV/AIDS, infection with human T-lymphotropic virus, immunosuppressant medications, and some pesticides. Eating large amounts of red meat and tobacco smoking may also increase the risk. Diagnosis, if enlarged lymph nodes are present, is usually by lymph node biopsy. Blood, urine, and bone marrow testing may also be useful in the diagnosis. Medical imaging may then be done to determine if and where the cancer has spread. Lymphoma most often spreads to the lungs, liver, and brain.
Treatment may involve one or more of the following: chemotherapy, radiation therapy, targeted therapy, and surgery. In some non-Hodgkin lymphomas, an increased amount of protein produced by the lymphoma cells causes the blood to become so thick that plasmapheresis is performed to remove the protein. Watchful waiting may be appropriate for certain types. The outcome depends on the subtype with some being curable and treatment prolonging survival in most. The five-year survival rate in the United States for all Hodgkin lymphoma subtypes is 85%, while that for non-Hodgkin lymphomas is 69%. Worldwide, lymphomas developed in 566,000 people in 2012 and caused 305,000 deaths. They make up 3–4% of all cancers, making them as a group the seventh-most common form. In children, they are the third-most common cancer. They occur more often in the developed world than the developing world.

More about Lymphoma